CD274 and neoplasm: Furthermore, this case showed low tumor mutational load and MSS predicting poor immunotherapy responsiveness including PD-1/PD-L1 treatment (Rosenberg et al. 2016; Snyder et al. 2014; Rizvi et al. 2015; Le et al. 2015).